Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinados

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Posted

73

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Please log in to like, share and comment!

Diddy approaches Trump for pardon; lawyer confirms

Music mogul Sean "Diddy" Combs, who is to be sentenced in October for his conviction on...

By 0 3

Mukesh Khanna's ‘Shakitamaan’ hits a roadblock

Mukesh Khanna's 'Shaktimaan' movie adaptation, a nostalgic project for '90s kids, faces...

By 0 3

Wild elephants enter settlements, locals in panic

KANCHANPUR: Wild elephants have begun entering Jai-Parsiya village in Laljhadi Rural...

By 0 15

NSA Ajit Doval in Russia amid Trump tariff threat: Key talks with Kremlin; will oil be on agenda?

By 0 16

IND vs ENG: 'Even the clouds cried on the pitch' - R Ashwin slams England

Indian spinner R Ashwin has criticized England's cricket team, particularly captain Ben Stokes...

By 0 25